On! Volume Hits 47M Cans—But Share Drops to 13.9% as ZYN and Velo Outpace Altria's Growth

Altria's On! nicotine pouches are selling more cans than ever—47.2 million in Q2 2026, up from 40.2 million in Q4 2025—but the brand is losing ground in a category growing so fast that volume gains aren't enough. On!'s U.S. retail share dropped from 16.8% to 13.9% year-over-year in H1 2026, a relative decline of more than 15%, even as the overall pouch market surged 27.2% to $7.29 billion.

The tension: pouches now make up 59.9% of the oral tobacco category (up 8.1 percentage points YoY), but ZYN and Velo are capturing that growth faster than On! is. Altria's answer is On! Plus—a new lineup backed by FDA marketing authorizations, 12mg strengths, and flavors like Blueberry Mint and Mango Pineapple—rolling out nationwide through Q3 2026. The question is whether portfolio expansion can turn On! into a legitimate #2, or whether the brand is locked into third place in a three-way race.

What the Numbers Show

On! off-take climbed steadily through the first half of 2026:

Q4 2025: 40.2 million cans
Q1 2026: 40.8 million cans
Q2 2026: 47.2 million cans

That 17% sequential jump from Q4 to Q2 was driven entirely by On! Plus, per Tobacco Insider. Brand awareness hit 57% among adult nicotine consumers aged 21-54 in H1 2026 (up from 53% a year prior), and the brand is now in 120,000 retail locations.

But retail share tells a different story:

H1 2025: 16.8%
H1 2026: 13.9% (down 2.9pp)
Q2 2026: 14.4% (up 1.0pp sequentially, but still down 1.7pp YoY)

The sequential gain in Q2 suggests On! Plus is working—just not fast enough to offset the category's explosive growth. U.S. smokeless tobacco convenience retail hit $13.4 billion for the 52 weeks ending June 14, up 12.7% YoY, with the spitless/pouch segment accounting for 54.4% of dollar share (up 6.2pp). Unit volume across smokeless rose 10.0% to 1.86 billion units, while traditional snuff fell 0.5% and chewing tobacco dropped 11.3%.

The On! Plus Bet

Altria is expanding On! Plus in three waves:

12mg strengths: Initial shipments in Florida, North Carolina, and Texas; nationwide rollout in Q3 2026.
New flavors: Blueberry Mint and Mango Pineapple entering the national market in Q4 2026.
Future line extensions: Planned for 2027 and beyond, leveraging the FDA's December 2025 authorization of six On! Plus products.

That regulatory clearance matters. As PouchDaily reported, the FDA explicitly cited lower levels of harmful constituents compared to traditional oral tobacco—the first authorization of its kind for pouches. Altria believes the prior authorizations create a streamlined PMTA pathway for supplemental reviews, potentially speeding future product launches.

The commercial logic: higher-strength 12mg options compete directly with ZYN's top SKUs, while flavors like Mango Pineapple target switchers from vaping or combustibles. Brand awareness at 57% is solid but still trails ZYN's near-ubiquity, and distribution at 120,000 stores is wide but not yet saturated.

Why Share Is Shrinking Despite Volume Growth

On!'s volume is rising because the category is booming—pouches grew 27.2% YoY to $7.29 billion—but ZYN and Velo are capturing a larger slice of that growth. When a category expands this fast, a brand can ship more product and still lose share if competitors are growing faster. That's the dynamic Altria is fighting.

The H1 2026 share drop (16.8% to 13.9%) represents a relative decline of more than 15%, per TobaccoIntelligence. The Q2 sequential gain (13.9% to 14.4%) suggests On! Plus is stabilizing the brand, but the year-over-year comparison (16.1% in Q2 2025 to 14.4% in Q2 2026) shows Altria is still playing catch-up.

What's Next

Altria's timeline:

Q3 2026: Nationwide expansion of 12mg On! Plus strengths.
Q4 2026: National launch of Blueberry Mint and Mango Pineapple.
2027+: Additional On! and On! Plus line extensions, leveraging the FDA authorization pathway.

The big question: can portfolio breadth reverse share losses in a category where ZYN holds dominant awareness and Velo (owned by BAT) is also expanding aggressively? On! has regulatory tailwinds, distribution scale, and a parent company (Altria) with deep retail relationships. But the H1 2026 data shows that volume growth alone isn't enough—Altria needs to capture a larger share of new pouch users, not just ride the category's overall lift.

Pouches now represent 59.9% of the oral tobacco category, up from 51.8% a year ago. That 8.1-percentage-point shift in a $13.4 billion market means billions of dollars are moving toward spitless products. On! is growing, but so is everyone else. Whether On! Plus can close the gap with ZYN—or even defend the #3 spot—depends on whether 12mg strengths and tropical flavors can pull switchers faster than the competition can.

SOURCES:

Tobacco Insider: USA: Nicotine Pouches — August 2026 update
TobaccoIntelligence: Altria expands On! pouch range as volume rises despite US retail market share drop
PouchDaily: FDA Authorizes Four On! Nicotine Pouches

Compare prices: Check On! pouch prices across retailers at PouchFinder.